Volume 16, Number 3—March 2010
Perspective
Preparing a Community Hospital to Manage Work-related Exposures to Infectious Agents in BioSafety Level 3 and 4 Laboratories
George F. Risi
, Marshall E. Bloom, Nancy P. Hoe, Thomas Arminio, Paul Carlson, Tamara Powers, Heinz Feldmann, and Deborah Wilson
, Marshall E. Bloom, Nancy P. Hoe, Thomas Arminio, Paul Carlson, Tamara Powers, Heinz Feldmann, and Deborah WilsonTable 1
BSL-4 laboratories planned or operational, 2009*
| Location | Status |
|---|---|
| United States | |
| Centers for Disease Control and Prevention, Atlanta, GA, USA | A |
| Georgia State University Viral Immunology Center, Atlanta | A |
| Boston University National Emerging Infectious Disease Laboratories, Boston, MA, USA | NA |
| United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA | A |
| Department of Homeland Security National Biodefense Analysis and Countermeasures Center, Frederick, MD, USA | NA |
| National Institute of Allergy and Infectious Diseases | |
| Integrated Research Facility, Frederick | NA |
| Rocky Mountain Laboratories, Hamilton, MT, USA | A |
| Southwest Foundation for Biomedical Research, San Antonio, TX, USA | A |
| University of Texas Medical Branch, Galveston, TX, USA | |
| Robert E. Shope MD BSL-4 Laboratory | A |
| Galveston National Biocontainment
Laboratory |
A |
| Other countries | |
| Geelong, Victoria, Australia | A |
| Winnipeg, Ontario, Canada | A |
| Taiwan | NA |
| London and Salisbury, UK | A, A |
| Lyon, France | A |
| Libreville, Gabon | A |
| Hamburg, Marburg, Berlin, and Greifswald, Germany | A, A, A, NA |
| Pune, India | NA |
| Rome, Italy | A |
| Bilthoven, the Netherlands | A |
| Novosibirsk, Russia | A |
| Sandringham, South Africa | NA |
| Solna, Sweden | A |
| Geneva and Spiez, Switzerland | A, NA |
*BSL-4, BioSafety Level 4; A, active; NA, nonactive.
